Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
20,317,336
-
Share change
-
+6,255,911
-
Total reported value
-
$139,156,228
-
Price per share
-
$6.90
-
Number of holders
-
33
-
Value change
-
+$43,178,567
-
Number of buys
-
25
-
Number of sells
-
4
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2020
As of 30 Sep 2020,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,317,336 shares.
The largest 10 holders included
Blackstone Group Inc, BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, Avidity Partners Management LP, Soleus Capital Management, L.P., Vivo Capital, LLC, ORBIMED ADVISORS LLC, Omega Fund Management, LLC, Sio Capital Management, LLC, and JANUS HENDERSON GROUP PLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.